Revelation Biosciences REVB
NASDAQ REVB
$0.83 -0.03 (-3.64%)
As of: Sep 29, 2026 · 3:59 PM EDT

Revelation Biosciences (REVB) Non-Current Assets (2020 - 2026)

Updated

Revelation Biosciences (REVB) posted Non-Current Assets of $813,416 for Q2 2026, compared with $35,170 a year earlier and down 3.0% from the prior quarter.

Analysis

Revelation Biosciences (REVB) Non-Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Revelation Biosciences' Non-Current Assets came in at $771,296.

  • Annual Non-Current Assets shows a five-year compound annual growth rate of -59.8% (FY2020 to FY2025).
  • In prior years, Revelation Biosciences' Non-Current Assets was $56,332 in FY2024 (-13.4%), $65,084 in FY2023 (-27.8%), $90,133 in FY2022 (-30.7%) and $130,141 in FY2021 (-99.8%).
  • Quarterly Non-Current Assets has run from a low of $23,919 in Q3 2025 to a high of $73.52 million in Q3 2021 over five years.
  • On a year-over-year basis, Non-Current Assets increased in 1 of the last five quarters, with an average decline of 33.2%.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2024, with growth of 13.9%; the weakest was Q3 2022, with a decline of 99.9%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $838,247 (Q1 2026), $771,296 (Q4 2025) and $23,919 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Revelation Biosciences 3.36 Mn -45.66 Mn - 813,416.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 813,416.00
Mar 31, 2026 838,247.00
Dec 31, 2025 771,296.00
Sep 30, 2025 23,919.00
Jun 30, 2025 35,170.00
Mar 31, 2025 42,390.00
Dec 31, 2024 56,332.00
Sep 30, 2024 81,242.00
Jun 30, 2024 70,774.00
Mar 31, 2024 77,994.00
Dec 31, 2023 65,084.00
Sep 30, 2023 71,346.00
Jun 30, 2023 77,608.00
Mar 31, 2023 83,870.00
Dec 31, 2022 90,133.00
Sep 30, 2022 96,395.00
Jun 30, 2022 102,657.00
Mar 31, 2022 108,919.00
Dec 31, 2021 130,141.00
Sep 30, 2021 73.52 Mn
API Access

Revelation Biosciences Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=REVB&period=max&api_key=YOUR_API_KEY